Skip to main content

Clinical Drug Investigation

Ausgabe 11/2018

Inhalt (10 Artikel)

Review Article

Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment

Alessio Baricich, Alessandro Picelli, Andrea Santamato, Stefano Carda, Alessandro de Sire, Nicola Smania, Carlo Cisari, Marco Invernizzi

Open Access Original Research Article

Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin

Kenneth Duchin, Giorgio Senaldi, Vance Warren, Thomas Marbury, Kenneth Lasseter, Hamim Zahir

Original Research Article

Regression and Genomic Analyses on the Association Between Dose-Normalized Mycophenolic Acid Exposure and Absolute Neutrophil Count in Steroid-Free, De Novo Kidney Transplant Recipients

Tony K. L. Kiang, Nilufar Partovi, R. Jean Shapiro, Jacob M. Berman, Abby C. Collier, Mary H. H. Ensom

Open Access Original Research Article

Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment

Giovanni Fazio, Ilaria Dentamaro, Rosanna Gambacurta, Pasquale Alcamo, Paolo Colonna

Open Access Original Research Article

Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment

Yukio Shimasaki, Masashi Sakaki, Minoru Itou, Tokurou Kobayashi, Masako Aso, Tomoya Kagawa, Takuya Saiki, Kumi Matsuno, Yuhei Sano, Kohei Shimizu, Shingo Kuroda, Emiko Koumura

Open Access Original Research Article

Evaluation of Drug–Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy Subjects

Nao Kawaguchi, Hiroki Koshimichi, Toru Ishibashi, Toshihiro Wajima

Open Access Short Communication

Riociguat for the Treatment of Raynaud’s Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)

Michael Huntgeburth, Johannes Kießling, Gerrit Weimann, Verena Wilberg, Soundos Saleh, Nicolas Hunzelmann, Stephan Rosenkranz

Case Report

Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer

Griet Hoste, Laurence Slembrouck, Lynn Jongen, Kevin Punie, Tom Matton, Sara Vander Borght, Isabelle Vanden Bempt, Johan Menten, Hans Wildiers, Giuseppe Floris, Carlos Arteaga, Patrick Neven